Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
The Bill & Melinda Gates Medical Research Institute will license an experimental tuberculosis vaccine from GlaxoSmithKline. An existing TB vaccine protects infants and children but not adolescents or adults. The institute plans to further develop the vaccine, M72/AS01E, which recently helped cut TB infections in half in a Phase II clinical trial of HIV-negative adults. The AS01E adjuvant used in the vaccine is also used in GSK’s herpes zoster vaccine, Shingrix.
This article has been sent to the following recipient: